TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Cohance Lifesciences Ltd.

COHANCE on NSE · 19 Nov 2026

NIFTY 500

459.45 ▲ +0.67 % on the day

Cohance Lifesciences Ltd. (COHANCE) closed at ₹459.45 on 19 Nov 2026, up 0.67 % on the day. Over the past year it is down 33.4 %; it stands 32.1 % below its 52-week high; it trades above its 200-day average. Its P/E is 370.5 on the last four quarters' profit. In Q2 FY27 (Jul-Sep 2026), profit fell 79.5 % and revenue fell 14.2 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

COHANCE · last year19 Nov 2026

The line uses prices adjusted for splits, bonuses and similar events.

1 week-2.6 %
1 month+0.4 %
3 months+0.9 %
1 year-33.4 %
From 52-week high-32.1 %distance from its highest close of the last year
200-day averageAboveprice above or below its 200-day average
P/E370.5on the last four quarters' profit
Typical daily turnover26.1₹ cr, median day of the last 60
Delivery48 %of traded shares taken into demat (not squared off)

Results in short

Q2 FY27 (Jul-Sep 2026), as the company reported it.

Revenue477₹ cr in the quarter, -14.2 % YoY
Profit15₹ cr in the quarter, -79.5 % YoY
Profit margin3.2 %profit as a share of revenue
Return on equity1.2 %ROE: last four quarters' profit on shareholders' funds

All 25 quarters

Cohance Lifesciences Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in